Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa L Smith

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Science & Justice : Journal of the Forensic Science Society|September 12, 2017
Forensic science and the right to access to justice: Testing the efficacy of self-examination intimate DNA swabs to enhance victim-centred responses to sexual violence in low-resource environmentsLisa L Smith, Jon H Wetton, Gurdeep K M Lall, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|May 6, 2014
Self-reported physical activity patterns among low-income Latina women in ArizonaLisa L Smith, Linda K Larkey, Denise J Roe, et al.
Blood|September 30, 2004
A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanismAmy J Johnson, Lisa L Smith, Jiuxiang Zhu, et al.
Blood|May 4, 2006
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemiaAmy J Johnson, David M Lucas, Natarajan Muthusamy, et al.
British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.
BMJ Open|September 7, 2021
Patterns of sexual violence against adults and children during the COVID-19 pandemic in Kenya: a prospective cross-sectional studySarah Rockowitz, Laura M Stevens, James C Rockey, et al.
Blood|April 4, 2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemiaZachary A Hing, Rose Mantel, Kyle A Beckwith, et al.
Leukemia & Lymphoma|March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphomaKristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
Leukemia Research|July 23, 2013
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaDeborah M Stephens, Amy S Ruppert, Kami Maddocks, et al.
Blood|October 21, 2016
Targeting BTK through microRNA in chronic lymphocytic leukemiaArianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Science & Justice : Journal of the Forensic Science Society|September 12, 2017
Forensic science and the right to access to justice: Testing the efficacy of self-examination intimate DNA swabs to enhance victim-centred responses to sexual violence in low-resource environmentsLisa L Smith, Jon H Wetton, Gurdeep K M Lall, et al.
Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|May 6, 2014
Self-reported physical activity patterns among low-income Latina women in ArizonaLisa L Smith, Linda K Larkey, Denise J Roe, et al.
Blood|September 30, 2004
A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanismAmy J Johnson, Lisa L Smith, Jiuxiang Zhu, et al.
Blood|May 4, 2006
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemiaAmy J Johnson, David M Lucas, Natarajan Muthusamy, et al.
British Journal of Haematology|October 24, 2007
Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemiaAmy J Johnson, Amy J Wagner, Carolyn M Cheney, et al.
BMJ Open|September 7, 2021
Patterns of sexual violence against adults and children during the COVID-19 pandemic in Kenya: a prospective cross-sectional studySarah Rockowitz, Laura M Stevens, James C Rockey, et al.
Blood|April 4, 2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemiaZachary A Hing, Rose Mantel, Kyle A Beckwith, et al.
Leukemia & Lymphoma|March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphomaKristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
Leukemia Research|July 23, 2013
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaDeborah M Stephens, Amy S Ruppert, Kami Maddocks, et al.
Blood|October 21, 2016
Targeting BTK through microRNA in chronic lymphocytic leukemiaArianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, et al.
Pageof 4